These CD4+ TRM cells conferred significant protection against heterosubtypic influenza infections in both mice and ferrets, highlighting the potential of this approach to overcome the strain-specific limitations of current vaccines and provide broader respiratory tract protection [37]. This evidence concerns the gene CD4 and influenza.